Solaris Biotech

Mantua, Italy Founded: 2002 • Age: 24 yrs Acquired By Donaldson Company
Fermenters and bioreactors are provided for RD and production sectors.

About Solaris Biotech

Solaris Biotech is an Industrial Goods & Manufacturing company based in Mantua (Italy) founded in 2002, and was acquired by Donaldson Company in November 2021. Fermenters and bioreactors are provided for RD and production sectors. It operates on a Direct-to-Consumer (D2C) and Professional Services model. Solaris Biotech offers products and services including Benchtop Bioreactors/Fermenters, Pilot Bioreactors/Fermenters, Industrial Bioreactors/Fermenters, and Filtration Systems. Its focus areas include Healthcare, Biotechnology, Bioprocessing Equipment and Industrial Goods. Its legal entity is Donaldson Italia S.R.L.

Company details

Solaris Biotech is involved in the design, engineering, and manufacturing of bioreactors, fermenters, and filtration systems for benchtop, pilot, and industrial scales. Solutions are provided across various sectors including biochemical, pharmaceutical, agricultural, and food beverage industries. Equipment and services are tailored to support research, development, and large-scale production needs. Turnkey solutions, basic engineering, and revamping services are also offered to assist clients from concept to commercialization. A global network of production, sales, and service branches ensures efficient service to an international customer base.

Key Metrics

Products & Services of Solaris Biotech

Solaris Biotech offers a comprehensive portfolio of products and services, including Benchtop Bioreactors/Fermenters, Pilot Bioreactors/Fermenters, Industrial Bioreactors/Fermenters, and Filtration Systems.

Benchtop Bioreactors/Fermenters
Biotech Equipment

Bioreactors are provided for lab-scale bioprocessing research.

Pilot Bioreactors/Fermenters
Biotech Equipment

Pilot-scale bioreactors are offered for mid-range production.

Industrial Bioreactors/Fermenters
Biotech Equipment

Large-scale bioreactors are designed for industrial bioprocessing needs.

Filtration Systems
Biotech Equipment

Filtration solutions are provided for bioprocessing scale applications.

Apps and channels of Solaris Biotech

its YouTube channel Solaris Biotech by Donaldson has 159 subscribers and 30 videos.

Solaris Biotech by Donaldson
YouTube 159 subscribers 30 videos Science & Technology
Open channel

Videos from Solaris Biotech

The most watched videos on Solaris Biotech's YouTube channel, Solaris Biotech by Donaldson (159 subscribers). Click a video to play it here.

What's inside the box? ONE unboxing
47.9K views
Solaris Biotech New Corporate Video short
15K views
LEM_1 Smart PCS
1.2K views
Pass the Mic Carbocode
932 views

More on Solaris Biotech by Donaldson.

Funding Insights of Solaris Biotech

  • Total Rounds 3
  • Last Round Grant β€” $54,286
  • First Round $293,220

    (Jan 2016)

  • Investors Count 2

All 3 funding rounds of Solaris Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2020$54,286Grant––
Jan 2020$56,095Grant––
Jan 2016$293,220Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in Solaris Biotech

Solaris Biotech has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Donaldson Company, European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Filtration systems are manufactured and supplied globally by Donaldson Company.
1915donaldson.comGurugram, India
Premium access

Investor details for Solaris Biotech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Solaris Biotech

261 people are tracked at Solaris Biotech (79 in leadership, 9 in board & advisors, 173 in team).

NameRoleGroup
Irene Acerbi
Managing DirectorLeadership
Maria Ortiz
Director Of Global Trade ComplianceLeadership
Guillermo Briseño
VP, Latin AmericaLeadership
Jon Wood
Vice President OperationsLeadership
Susanne Wall
Director, Sales Operations Mobile Solutions AftermarketLeadership
Linda Freiboth
Human Resources DirectorLeadership
Izzet Moreno
Vice President, Industrial Aftermarket And ServicesLeadership
Paul Henry
Director Of OperationsLeadership
Kristof Decoster
Director Of EngineeringLeadership
Sarika Dhadwal
Senior Director, Investor Relations & ESGLeadership
David Mulder
Chief Technology Officer, Donaldson Company, Inc.Leadership
Davis Moravec
Director Of Engineering - Life Science ConsumablesLeadership
Paula Jones
Director Of BenefitsLeadership
Graham Allison
Senior IT Director - Global Business SystemsLeadership
Amy C. Becker
VP, General Counsel & SecretaryLeadership
Tod E. Carpenter
Chairman, President & CEOLeadership
Mary Callahan
Director, Engine Special Projects At Donaldson Co.Leadership
Sylvia Figueredo
Latam Marketing HeadLeadership
Renan Jarussi
Senior HR Business PartnerLeadership
John Fitzgerald
Product Director, Engine Air Filtration ProductsLeadership

241 more people are available in the full profile.

Premium access

Complete people profiles for Solaris Biotech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Solaris Biotech

4 dated milestones of Solaris Biotech across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded Solaris Biotech is founded.
  2. Funding First funding round of $293K.
  3. Funding Latest funding round, Grant, of $54K.
  4. Exit Acquired by Donaldson Company.

Web traffic of Solaris Biotech

The website of Solaris Biotech (solarisbiotech.com) receives about 2.7K visits a month.

  • Monthly visits
    2.7K

    ▼ 7% vs previous month

Similar websites

Websites whose visitors overlap most with Solaris Biotech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
assind.mn.it
assind.mn.it
100%
–
ades-srl.it
ades-srl.it
98%
–
progemaeng.com
progemaeng.com
94%
–
afablabresources.com
afablabresources.com
86%
#4,358,184–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Solaris Biotech

Premium access

Complete news archive for Solaris Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Solaris Biotech

Solaris Biotech was founded in 2002 and raised its 1st funding round 14 years after it was founded.

Solaris Biotech is headquartered in Mantua, Italy. It is registered at Mantua, Lombardy, Italy.

Solaris Biotech is involved in the design, engineering, and manufacturing of bioreactors, fermenters, and filtration systems for benchtop, pilot, and industrial scales. Solutions are provided across various sectors including biochemical, pharmaceutical, agricultural, and food beverage industries. Equipment and services are tailored to support research, development, and large-scale production needs. Turnkey solutions, basic engineering, and revamping services are also offered to assist clients from concept to commercialization. A global network of production, sales, and service branches ensures efficient service to an international customer base.

Solaris Biotech offers Benchtop Bioreactors/Fermenters, Pilot Bioreactors/Fermenters, Industrial Bioreactors/Fermenters, and Filtration Systems.

Solaris Biotech has 3 investors. Key investors include Donaldson Company, European Union, and EIC Fund.

Solaris Biotech operates through Donaldson Italia S.R.L..

Yes. Solaris Biotech was acquired by Donaldson Company in November 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available